NEW YORK (GenomeWeb News) – Dutch firm InteRNA Technologies and German firm Cenix BioScience today said that they will collaborate on screening assays for miRNAs and therapeutic targets for cancer.
 
Cenix will use InteRNA’s lentiviral-based miRNA overexpression library in high-throughput screening assays in combination with high-content, multi-parametric phenotypic analyses to determine the biological role of individual miRNAs and to identify cancer drug targets.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.